1,061 research outputs found
On renormalization group flows and the a-theorem in 6d
We study the extension of the approach to the a-theorem of Komargodski and
Schwimmer to quantum field theories in d=6 spacetime dimensions. The dilaton
effective action is obtained up to 6th order in derivatives. The anomaly flow
a_UV - a_IR is the coefficient of the 6-derivative Euler anomaly term in this
action. It then appears at order p^6 in the low energy limit of n-point
scattering amplitudes of the dilaton for n > 3. The detailed structure with the
correct anomaly coefficient is confirmed by direct calculation in two examples:
(i) the case of explicitly broken conformal symmetry is illustrated by the free
massive scalar field, and (ii) the case of spontaneously broken conformal
symmetry is demonstrated by the (2,0) theory on the Coulomb branch. In the
latter example, the dilaton is a dynamical field so 4-derivative terms in the
action also affect n-point amplitudes at order p^6. The calculation in the
(2,0) theory is done by analyzing an M5-brane probe in AdS_7 x S^4.
Given the confirmation in two distinct models, we attempt to use dispersion
relations to prove that the anomaly flow is positive in general. Unfortunately
the 4-point matrix element of the Euler anomaly is proportional to stu and
vanishes for forward scattering. Thus the optical theorem cannot be applied to
show positivity. Instead the anomaly flow is given by a dispersion sum rule in
which the integrand does not have definite sign. It may be possible to base a
proof of the a-theorem on the analyticity and unitarity properties of the
6-point function, but our preliminary study reveals some difficulties.Comment: 41 pages, 5 figure
Patterns of multimorbidity in working Australians
Background: Multimorbidity is becoming more prevalent. Previously-used methods of assessing multimorbidity relied on counting the number of health conditions, often in relation to an index condition (comorbidity), or grouping conditions based on body or organ systems. Recent refinements in statistical approaches have resulted in improved methods to capture patterns of multimorbidity, allowing for the identification of nonrandomly occurring clusters of multimorbid health conditions. This paper aims to identify nonrandom clusters of multimorbidity.Methods: The Australian Work Outcomes Research Cost-benefit (WORC) study cross-sectional screening dataset (approximately 78,000 working Australians) was used to explore patterns of multimorbidity. Exploratory factor analysis was used to identify nonrandomly occurring clusters of multimorbid health conditions.Results: Six clinically-meaningful groups of multimorbid health conditions were identified. These were: factor 1: arthritis, osteoporosis, other chronic pain, bladder problems, and irritable bowel; factor 2: asthma, chronic obstructive pulmonary disease, and allergies; factor 3: back/neck pain, migraine, other chronic pain, and arthritis; factor 4: high blood pressure, high cholesterol, obesity, diabetes, and fatigue; factor 5: cardiovascular disease, diabetes, fatigue, high blood pressure, high cholesterol, and arthritis; and factor 6: irritable bowel, ulcer, heartburn, and other chronic pain. These clusters do not fall neatly into organ or body systems, and some conditions appear in more than one cluster.Conclusions: Considerably more research is needed with large population-based datasets and a comprehensive set of reliable health diagnoses to better understand the complex nature and composition of multimorbid health conditions
Contrast Adaptive Tissue Classification by Alternating Segmentation and Synthesis
Deep learning approaches to the segmentation of magnetic resonance images
have shown significant promise in automating the quantitative analysis of brain
images. However, a continuing challenge has been its sensitivity to the
variability of acquisition protocols. Attempting to segment images that have
different contrast properties from those within the training data generally
leads to significantly reduced performance. Furthermore, heterogeneous data
sets cannot be easily evaluated because the quantitative variation due to
acquisition differences often dwarfs the variation due to the biological
differences that one seeks to measure. In this work, we describe an approach
using alternating segmentation and synthesis steps that adapts the contrast
properties of the training data to the input image. This allows input images
that do not resemble the training data to be more consistently segmented. A
notable advantage of this approach is that only a single example of the
acquisition protocol is required to adapt to its contrast properties. We
demonstrate the efficacy of our approaching using brain images from a set of
human subjects scanned with two different T1-weighted volumetric protocols.Comment: 10 pages. MICCAI SASHIMI Workshop 202
Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
BACKGROUND: Alpha-Synuclein (alpha-syn), a 140 amino acid protein associated with presynaptic membranes in brain, is a major constituent of Lewy bodies in Parkinson's disease (PD). Three missense mutations (A30P, A53T and E46K) in the alpha-syn gene are associated with rare autosomal dominant forms of familial PD. However, the regulation of alpha-syn's cellular localization in neurons and the effects of the PD-linked mutations are poorly understood. RESULTS: In the present study, we analysed the ability of cytosolic factors to regulate alpha-syn binding to synaptic membranes. We show that co-incubation with brain cytosol significantly increases the membrane binding of normal and PD-linked mutant alpha-syn. To characterize cytosolic factor(s) that modulate alpha-syn binding properties, we investigated the ability of proteins, lipids, ATP and calcium to modulate alpha-syn membrane interactions. We report that lipids and ATP are two of the principal cytosolic components that modulate Wt and A53T alpha-syn binding to the synaptic membrane. We further show that 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16:0 PAF) is one of the principal lipids found in complex with cytosolic proteins and is required to enhance alpha-syn interaction with synaptic membrane. In addition, the impaired membrane binding observed for A30P alpha-syn was significantly mitigated by the presence of protease-sensitive factors in brain cytosol. CONCLUSION: These findings suggest that endogenous brain cytosolic factors regulate Wt and mutant alpha-syn membrane binding, and could represent potential targets to influence alpha-syn solubility in brain
Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
The pathological hallmarks of Parkinson's disease (PD) are degeneration of dopamine (DA) neurons of the substantia nigra (SN) and the presence of alpha-synuclein (α-syn)-rich Lewy bodies in DA cells that remain. To model these aspects of the disease, we previously showed that high titer (5.1Ă10exp12 gp/ml) AAV1/2 driven expression of A53T α-syn in the SN of rats caused nigrostriatal pathology including a loss of DA neurons, but also with toxicity in the GFP control group. In the current study, we evaluate the effects of two lower titers by dilution of the vector (1â¶3 [1.7Ă10exp12] and 1â¶10 [5.1Ă10exp11]) to define a concentration that produced pathology specific for α-syn. In GFP and empty vector groups there were no behavioural or post-mortem changes at 3 or 6 weeks post-administration at either vector dose. Dilution of the AAV1/2 A53T α-syn (1â¶3) produced significant paw use asymmetry, reductions in striatal tyrosine hydroxylase (TH), and increases in DA turnover at 3 weeks in the absence of overt pathology. By 6 weeks greater evidence of pathology was observed and included, reductions in SN DA neurons, striatal DA, TH and DA-transporter, along with a sustained behavioural deficit. In contrast, the 1â¶10 AAV1/2 A53T α-syn treated animals showed normalization between 3 and 6 weeks in paw use asymmetry, reductions in striatal TH, and increased DA turnover. Progression of dopaminergic deficits using the 1â¶3 titer of AAV1/2 A53Tα-syn provides a platform for evaluating treatments directed at preventing and/or reversing synucleinopathy. Use of the 1â¶10 titer of AAV1/2 A53T α-syn provides an opportunity to study mechanisms of endogenous compensation. Furthermore, these data highlight the need to characterize the titer of vector being utilized, when using AAV to express pathogenic proteins and model disease process, to avoid producing non-specific effects
âExcellence R Usâ: university research and the fetishisation of excellence
The rhetoric of âexcellenceâ is pervasive across the academy. It is used to refer to research outputs as well as researchers, theory and education, individuals and organisations, from art history to zoology. But does âexcellenceâ actually mean anything? Does this pervasive narrative of âexcellenceâ do any good? Drawing on a range of sources we interrogate âexcellenceâ as a concept and find that it has no intrinsic meaning in academia. Rather it functions as a linguistic interchange mechanism. To investigate whether this linguistic function is useful we examine how the rhetoric of excellence combines with narratives of scarcity and competition to show that the hypercompetition that arises from the performance of âexcellenceâ is completely at odds with the qualities of good research. We trace the roots of issues in reproducibility, fraud, and homophily to this rhetoric. But we also show that this rhetoric is an internal, and not primarily an external, imposition. We conclude by proposing an alternative rhetoric based on soundness and capacity-building. In the final analysis, it turns out that that âexcellenceâ is not excellent. Used in its current unqualified form it is a pernicious and dangerous rhetoric that undermines the very foundations of good research and scholarship
Comments on Holographic Entanglement Entropy and RG Flows
Using holographic entanglement entropy for strip geometry, we construct a
candidate for a c-function in arbitrary dimensions. For holographic theories
dual to Einstein gravity, this c-function is shown to decrease monotonically
along RG flows. A sufficient condition required for this monotonic flow is that
the stress tensor of the matter fields driving the holographic RG flow must
satisfy the null energy condition over the holographic surface used to
calculate the entanglement entropy. In the case where the bulk theory is
described by Gauss-Bonnet gravity, the latter condition alone is not sufficient
to establish the monotonic flow of the c-function. We also observe that for
certain holographic RG flows, the entanglement entropy undergoes a 'phase
transition' as the size of the system grows and as a result, evolution of the
c-function may exhibit a discontinuous drop.Comment: References adde
Does parallel item content on WOMAC's Pain and Function Subscales limit its ability to detect change in functional status?
BACKGROUND: Although the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) is considered the leading outcome measure for patients with osteoarthritis of the lower extremity, recent work has challenged its factorial validity and the physical function subscale's ability to detect valid change when pain and function display different profiles of change. This study examined the etiology of the WOMAC's physical function subscale's limited ability to detect change in the presence of discordant changes for pain and function. We hypothesized that the duplication of some items on the WOMAC's pain and function subscales contributed to this shortcoming. METHODS: Two eight-item physical function scales were abstracted from the WOMAC's 17-item physical function subscale: one contained activities and themes that were duplicated on the pain subscale (SIMILAR-8); the other version avoided overlapping activities (DISSIMILAR-8). Factorial validity of the shortened measures was assessed on 310 patients awaiting hip or knee arthroplasty. The shortened measures' abilities to detect change were examined on a sample of 104 patients following primary hip or knee arthroplasty. The WOMAC and three performance measures that included activity specific pain assessments â 40 m walk test, stair test, and timed-up-and-go test â were administered preoperatively, within 16 days of hip or knee arthroplasty, and at an interval of greater than 20 days following the first post-surgical assessment. Standardized response means were used to quantify change. RESULTS: The SIMILAR-8 did not demonstrate factorial validity; however, the factorial structure of the DISSIMILAR-8 was supported. The time to complete the performance measures more than doubled between the preoperative and first postoperative assessments supporting the theory that lower extremity functional status diminished over this interval. The DISSIMILAR-8 detected this deterioration in functional status; however, no significant change was noted for the SIMILAR-8. The WOMAC pain scale demonstrated a slight reduction in pain and the performance specific pain measures did not reflect a change in pain. All measures showed substantial improvement over the second assessment interval. CONCLUSIONS: These findings support the hypothesis that activity overlap on the pain and function subscales plays a causal role in limiting the WOMAC physical function subscale's ability to detect change
Photochemical activation of TRPA1 channels in neurons and animals
Optogenetics is a powerful research tool because it enables high-resolution optical control of neuronal activity. However, current optogenetic approaches are limited to transgenic systems expressing microbial opsins and other exogenous photoreceptors. Here, we identify optovin, a small molecule that enables repeated photoactivation of motor behaviors in wild type animals. Surprisingly, optovin's behavioral effects are not visually mediated. Rather, photodetection is performed by sensory neurons expressing the cation channel TRPA1. TRPA1 is both necessary and sufficient for the optovin response. Optovin activates human TRPA1 via structure-dependent photochemical reactions with redox-sensitive cysteine residues. In animals with severed spinal cords, optovin treatment enables control of motor activity in the paralyzed extremities by localized illumination. These studies identify a light-based strategy for controlling endogenous TRPA1 receptors in vivo, with potential clinical and research applications in non-transgenic animals, including humans
- âŠ